MELANOMA BRIDGE 2015
December 1-4, 2015
Sanjiv Agarwala
St. Luke's University Hospital and Temple University, Bethlehem, Pennsylvania
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon
Gerardo Botti
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Jorge Camarero
Oncology Area, Spanish Agency for Medicines and Medical Devices, AEMPS, Spain
Oncology assessor at the European Medicines Agency, EMA
Alessandra Cesano
NanoString Technologies, Seattle, Washington
Pier Luigi Canonico
Department of Scienze del Farmaco, University of Piemonte Orientale, Novara, Italy
Gennaro Ciliberto
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Michael Davies
Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Texas
Francesco De Lorenzo
Italian Federation of Volunteer-based Cancer Organizations, FAVO
Sandra Demaria
New York University School of Medicine and NYU Langone Medical Center Alexandria Center for Life Sciences, New York
Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich
Alexander Eggermont
Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France
Soldano Ferrone
Massachusetts General Hospital, Boston, Massachusetts
Paolo Foggi*
Italian Medicines Agency, AIFA
Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon
Yang Xin Fu
Donnelley Biological Sciences Learning Center, University of Chicago, Illinois
Thomas F. Gajewski
Department of Pathology and Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois
Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France
Claus Garbe
Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen, Germany
Valerie Guild
AIM at Melanoma, Richmond, California
Claudio Jommi
Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy
Howard Kaufman
Rutgers Cancer Institute of New Jersey, New Jersey
Samir Khleif
Georgia Regents University Cancer Center, Augusta, Georgia
John M. Kirkwood
Melanoma and Skin Cancer Program University of Pittsburgh Cancer Institute, Pennsylvania
Michael Krauthammer
Yale University School of Medicine, Department of Pathology, New Haven, Connecticut
Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, California
Michele Maio
Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Italy
Francesco M. Marincola
Sidra Medical and Research Center, Doha, Qatar
Giuseppe Masucci
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
Deborah Morrison
National Institute for Health and Care Excellence, NICE
Nicola Mozzillo
Department Melanoma and Soft Tissues, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Franck Pages
Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou, Paris, France
Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy
Francesco Perrone
Clinical Trials Unit, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Michael Postow
Memorial Sloan Kettering Cancer Center, New York
Igor Puzanov
Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee
Tilman Rau
Institute of Pathology, University of Bern, Switzerland
Licia Rivoltini
National Cancer Institute of Milan, Italy
Paola Queirolo
National Institute for Cancer Research, Genova, Italy
Stefani Spranger
Department of Patholog, University of Chicago, Illinois
David Frank Stroncek
Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland
Ahmad Tarhini
Melanoma and Skin Cancer Program University of Pittsburgh Cancer Institute, Pennsylvania
Janis M. Taube
Johns Hopkins University SOM, Baltimore, Maryland
Alessandro Testori
Dermato-oncology Surgery Division, European Institute of Oncology, Milan, Italy
Magdalena Thurin
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland
Ena Wang
Sidra Medical and Research Centre, Doha, Qatar
Jennifer A. Wargo
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Cassian Yee
Solid Tumor Cell Therapy and ACT Platform, UT MD Anderson Cancer Center, Texas
Hassane Zarour
University of Pittsburgh Cancer Institute Hillman Cancer Center, Pennsylvania
Laurence Zitvogel
Institut Gustave Roussy, Villejuif, Paris-Sud, France
* To be confirmed
For information please contact info@melanomabridge.org
